Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GQ1005 vs T-DM1 in HER2-Positive Breast Cancer
NCT07673029Phase 3Recruiting
- Sponsor
- GeneQuantum Biosciences
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 3 trial of gq1005 in breast cancer, sponsored by GeneQuantum Biosciences. Started Jan 2025; status: recruiting.
02
Drugs
gq1005
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07673029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07673029.